A375 is a human-derived melanoma cell line harboring a BRAF mutation due to the substitution of valine for glutamic acid at codon 600, termed V600E resulting in constitutive activation, aggressive proliferation, and high BCL-2 expression. This evidence concerns the gene BCL2 and melanoma.